|
|
 |
Zebeta :Beta-blocking medications slow the heart rate and reduce
hypertension (high blood pressure).:
Side Effects:
You may experience dizziness, lightheadedness, drowsiness, and
blurred vision as your body adjusts to the medication.
Use caution engaging in activities requiring alertness.
Because beta-blockers reduce blood circulation to the extremities,
your hands and feet may be more susceptible to the cold.
Dress warm.
Inform your doctor if you develop easy bruising or bleeding, swollen
hands or feet, confusion, depression or a sore throat.
In the unlikely event you have an allergic reaction to this drug,
seek medical attention immediately.
Symptoms of an allergic reaction include rash, itching, swelling,
dizziness or trouble breathing. 
Precautions:
Before taking this drug, tell your doctor if you have a history
of heart, kidney, or liver disease, asthma, bronchitis, emphysema,
or other lung disease, diabetes, an overactive thyroid gland or
any drug allergies.
Before having surgery, tell the doctor or dentist in charge that
you are taking a beta-blocker.
This drug should be used only if clearly needed during pregnancy.
Discuss the risks and benefits with your doctor.
This drug is excreted into breast milk and though no problems have
been noted, the possibility for adverse effects to the infant exists.
Consult your doctor before breast-feeding.
For information on Medic Alert(TM) call 1-800-854-1166.
In Canada call 1-800-668-1507.

Related Drugs:
Zebeta 10 mg Tablet - Prescription
Zebeta 5 mg Tablet - Prescription, 

Generic Name: Bisoprolol Fumarate
Ziac_PI
http://www.fda.gov/medwatch/SAFETY/2003/03Jan_labels/Ziac_PI.pdf
bisoprolol fumarate, doses, patients, hydrochlorothiazide,
Ziac, agents, HCTZ, administration, therapy, tablets, treatment,
decreases, adverse, electrolyte.
ZIAC (bisoprolol fumarate and hydrochlorothiazide) is
indicated for the treatment of hypertension.
Bisoprolol fumarate is a beta 1-selective (cardioselective) adrenoceptor
blocking agent without significant membrane stabilizing or intrinsic
sympathomimetic activities in its therapeutic dose range.
Because of its beta1-selectivity, this is less likely with bisoprolol
fumarate.
However, patients subject to spontaneous hypoglycemia, or diabetic
patients receiving insulin or oral hypoglycemic agents, should be
cautioned about these possibilities.
Miscellaneous: The oculomucocutaneous syndrome associated with the
beta-blocker practolol has not been reported with bisoprolol fumarate
during investigational use or extensive foreign marketing experience.
The following adverse experiences, in addition to those listed in
the above table, have been reported with hydrochlorothiazide (generally
with doses of 25 mg or greater).
dubachchf
ventricular, patients, therapy, exercise, rotation, cardiac,
beta-blockade, placebo, bisoprolol fumarate, techniques, ejection
fraction, MRI, motion, end-diastole.
Background Recent data suggest that beta-blockers can
be beneficial in subgroups of patients with chronic heart failure
(CHF).
We examined the effects of bisoprolol fumarate on exercise capacity
and left ventricular volume with magnetic resonance imaging (MRI)
and applied a novel high-resolution MRI tagging technique to determine
myocardial rotation and relaxation velocity.
Statistical Graphics Corporation software (Bethesda, Md) was used
to perform multivariante analysis of variance procedures between
patients randomized to bisoprolol fumarate or placebo.
Sample size estimates were on the basis of variance obtained from
our previous studies of ventricular volumes with MRI, in which the
standard deviation of left ventricular end-diastolic volume was
roughly 40 mL.
03009news
http://www.healthservices.gov.bc.ca/pharme/newsletter/03009news.pdf
Tab, Carvedilol, LCA, GLA, PharmaCare, PMS Pms-Carvedilol
Tab, APX Apo-Carvedilol Tab, PharmaCare newsletter, GLA Coreg, dispensing
fees, Oral Liquid, RPH Ratio-Paroxetine Tab, Chloral Hydrate, DIN.
PharmaCare program for British Columbia's community pharmacists.
Page 3 of 3 Please be advised that Tylenol with Codeine No. 3 Tablets,
DIN 2163926, is now a FULL BENEFIT for eligible patients, effective
October 27, 2003.
03008news
http://www.healthservices.gov.bc.ca/pharme/newsletter/03008news.pdf
Tab, PharmaCare, PMS, drug, APX, Rhoxal-Pravastatin Tab,
RXP, LCA, special authority, PharmaCare newsletter, resubmission,
Pms-Carvedilol Tab, Apo-Carvedilol Tab, Ratio-Paroxetine Tab.
PharmaCare program for British Columbia's community pharmacists.
8:00am to 4:00pm, Saturday and Sunday Registration via the Web and
IVR continue to be available outside these hours.
PharmaCare currently has two Acting Executive Directors, Phyllis
Chuly and Suzanne Solven.
Suzanne is responsible for policy related to drug benefit decisions,
the special authorization process and Federal/Provincial/Territorial
initiatives related to the Common Drug Review, generic drug harmonization
and best practices.
Please forward inquiries to the appropriate A/Executive Director.
Drug Name correction Addition to new booklet.



|